Shannon Wiley
Shannon Wiley focuses her practice on healthcare regulatory and transactional matters with a specific emphasis in the pharmaceutical industry. Shannon provides clients with legal guidance steeped in a deep business understanding, such as assisting clients with the development of limited distribution networks, pharmacy services agreements, hub arrangements, data services arrangements, and GPO agreements. She advises clients on regulations such as the Anti-Kickback Statute, the Health Insurance Portability and Accountability Act (HIPAA), the Civil Monetary Penalty Law, and FDA regulations such as the Drug Supply Chain Security Act. Shannon also provides guidance on the healthcare regulatory aspects of mergers and acquisitions.
Memberships
American Health Law Association (AHLA)
National Association of Specialty Pharmacies (NASP)
American Pharmacists Association (APhA)
National Infusion Center Association
Memphis Bar Association — Health Law Section, Chair (2019) and Board Member (2015-2019); CLE Committee, Chair (2015-2016)
Representative Experience
-
Read More
Representation of J. Knipper and Company, Inc. – one of the largest suppliers of end-to-end pharmaceutical samples management services and a Court Square portfolio company – and its affiliates, including KnippeRx, in its acquisition of Eagle Pharmacy – a Florida-based full-service, direct-to-patient (DTP) pharmacy. This strategic transaction for KnippeRx will expand the company’s pharmacy programs, scale and automation capabilities.
-
Read More
Representation of Linden Capital Partners, as lead healthcare regulatory counsel, in its investment in Vital Care, Inc., a pharmacy franchisor of home infusion services. Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry
-
Read More
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
-
TT Capital Partners, NovaQuest Capital Management, and Frist Cressey Ventures Invests in InformedDNARead More
Representation of TT Capital Partners (TTCP), NovaQuest Capital Management (NovaQuest) and Frist Cressey Ventures in its recapitalization and growth equity investment in InformedDNA, the nation’s largest provider of genetic services
-
Read More
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
-
Read More
We represented HealthTrust (Healthtrust Purchasing Group, L.P.) in its definitive agreement to acquire Resource Optimization & Innovation (ROi), a recognized leader in healthcare supply chain management.
-
Read More
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
-
Read More
Represented Community Pharmacy Partners in its investment by Altaris Capital Partners, LLC.
-
Read More
Served as lead healthcare regulatory counsel to Amazon (Nasdaq: AMZN) in its acquisition of PillPack
-
Read More
Provided healthcare regulatory and antitrust counsel to Avella Specialty Pharmacy in its sale to OptumRx
Publications
Past Events
Media Mentions & Firm News
Additional News & Insights
Recent Article:
- Co-author – “HHS Issues Guidance on Permitted Remuneration for Prescription Refill Reminders in the Absence of Patient Authorization,” Health Lawyers Weekly (October 11, 2013)
Recent Presentation:
- “What You Don’t Know Can Hurt You: The Top 10 Things You Need to Know About Health Law for Your Practice,” Memphis Bar Association Bench Bar & Boardroom Conference (May 2014)
Accolades
Mid-South Super Lawyers “Rising Star” (2013-2020)
Cecil C. Humphreys Law Review